慢性乙型肝炎治疗后肝脏硬度值变化与纤维化逆转的关系
CSTR:
作者:
作者单位:

作者简介:

郭章允,男,主治医师,主要从事消化内科工作。

通讯作者:

中图分类号:

R 512.6+ 2;R 575.2

基金项目:


Relationship Between Changes in Liver Stiffness Value and Fibrosis Reversal after Treatment for Chronic Hepatitis B
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:探究慢性乙型肝炎(CHB)患者治疗后肝脏硬度值(LSM)变化与肝纤维化逆转的关系。 方法:选择 2020 年 4 月至 2021 年 8 月期间山东大学第二医院成武分院收治的 CHB 患者 80 例作为研究对象,患者均接受过抗病毒治疗, 治疗后按照是否肝纤维化逆转分为两组,分别为逆转组(38 例)与非逆转组(42 例)。收集患者的基线资料[年龄、性别、 饮酒史、吸烟、体质量指数(BMI)]及治疗前实验室生化指标,并行超声检测 LSM,计算谷草转氨酶与血小板数比值 (APRI)、基于 4 项因素的肝纤维化指数(FIB–4)。采用多因素 logistic 回归分析纤维化逆转的影响因素,观察 LSM 是否 对肝纤维化逆转产生影响。 结果:逆转组与非逆转组在血小板数(PLT)> 300×109 ·L-1、乙型肝炎病毒脱氧核糖核酸 (HBV DNA)水平、LSM 分级、ΔLSM 方面比较,差异均具有统计学意义(P < 0.05)。多因素 logistic 回归分析结果 表明,治疗前 PLT > 300×109 ·L-1 及治疗前 LSM 9.4 ~ 17.0 kPa、LSM > 17.0 kPa 是肝纤维化逆转的危险因素(OR > 1, P < 0.05),HBV DNA 4.0 ~ 7.0 lg IU·mL-1 、HBV DNA > 7.0 lg IU·mL-1 不是肝纤维化逆转的独立影响因素(P > 0.05)。 ΔLSM 5 ~ 10 kPa、ΔLSM > 10 kPa 是肝纤维逆转的保护因素(OR < 1,P < 0.05)。 结论:治疗前 PLT > 300×109 ·L-1 及治疗前 LSM 9.4 ~ 17.0 kPa、LSM > 17.0 kPa 是肝纤维化逆转的危险因素,ΔLSM 5 ~ 10 kPa、ΔLSM > 10 kPa 是肝纤维 逆转的保护因素。

    Abstract:

    AbstractObjective To investigate the relationship between the change of liver stiffness measurement (LSM) and the reversal of liver fibrosis in chronic hepatitis B (CHB) patients after treatment. Methods A-total of 80 patients with CHB admitted to Chengwu Branch of the Second Hospital of Shandong University between April 2020 and August 2021 were selected as study subjects, all of whom had received antiviral treatment and were divided into two groups according to whether they had reversed liver fibrosis after treatment, namely the reversal group (38 patients) and the non-reversal group (42 patients). Baseline data [age, gender, history of alcohol consumption, smoking, body mass index (BMI)] and pretreatment laboratory biochemical indexes were collected, and ultrasound was performed to detect the LSM, to calculate the azotransferase to platelet count ratio (APRI), and the liver fibrosis index based on 4 factors (FIB-4). Multifactorial logistic regression was used to analyse the influencing factors of fibrosis reversal and to observe whether LSM had an effect on liver fibrosis reversal. Results The differences between the reversal group and the non-reversal group in terms of platelet count (PLT) > 300×109 ·L-1, hepatitis B virus deoxyribonucleic acid (HBV DNA) level, LSM grading, and ΔLSM were statistically significant (P < 0.05). The results of multifactorial logistic regression analysis showed that pretreatment PLT > 300×109 ·L-1 and pretreatment LSM 9.4 ~ 17.0 kPa, LSM > 17.0 kPa were the risk factors for hepatic fibrosis reversal (OR > 1, P < 0.05), HBV DNA 4.0 ~ 7.0 lg IU·mL-1 、HBV DNA > 7.0 lg IU·mL-1 were not independent influencing factors for liver fibrosis reversal (P > 0.05). ΔLSM 5 ~ 10 kPa and ΔLSM > 10 kPa were protective factors for liver fiber reversal (OR < 1, P < 0.05). Conclusion Pre-treatment PLT > 300×109 ·L-1 and pre-treatment LSM 9.4 ~ 17.0 kPa and LSM > 17.0 kPa were risk factors for hepatic fibrosis reversal, and ΔLSM 5 ~ 10 kPa and ΔLSM > 10 kPa were protective factors for hepatic fiber reversal.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-06-17
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-30
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭